Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema

References

• RogersSMcIntoshRLCheungNThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaOphthalmology20101172313319 e31120022117
   PubMed Web of Science ®Google Scholar
• LaatikainenLKohnerEMFluorescein angiography and its prognostic significance in central retinal vein occlusionBr J Ophthalmol1976606411418952814
   PubMed Web of Science ®Google Scholar
• McIntoshRLMohamedQSawSMWongTYInterventions for branch retinal vein occlusion: an evidence-based systematic reviewOphthalmology2007114583585417397923
   PubMed Web of Science ®Google Scholar
• No authors listedEvaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M reportOphthalmology199510210142514339097788
   PubMed Web of Science ®Google Scholar
• MohamedQMcIntoshRLSawSMWongTYInterventions for central retinal vein occlusion: an evidence-based systematic reviewOphthalmology2007114350751952417324695
   PubMed Web of Science ®Google Scholar
• BrownDMCampochiaroPASinghRPRanibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III studyOphthalmology2010117611241133.e112120381871
   PubMed Web of Science ®Google Scholar
• KingeBStordahlPBForsaaVEfficacy of ranibizumab in patients with macular edema secondary to central retinal vein occlusion: results from the sham-controlled ROCC studyAm J Ophthalmol2010150331031420591399
   PubMed Web of Science ®Google Scholar
• EpsteinDLAlgverePVvon WendtGSeregardSKvantaABevacizumab for macular edema in central retinal vein occlusion: a prospective, randomized, double-masked clinical studyOphthalmology201211961184118922424833
   PubMed Web of Science ®Google Scholar
• TanMHMcAllisterILGilliesMERandomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusionAm J Ophthalmol20141571237247 e23124112635
   PubMed Web of Science ®Google Scholar
• IpMSScottIUVanVeldhuisenPCA randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion: the Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study report 5Arch Ophthalmol200912791101111419752419
   PubMedGoogle Scholar
• HallerJABandelloFBelfortRJrRandomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusionOphthalmology2010117611341146.e113320417567
   PubMed Web of Science ®Google Scholar
• FlomanNZorUMechanism of steroid action in ocular inflammation: inhibition of prostaglandin productionInvest Ophthalmol Vis Sci19771616973319076
   PubMed Web of Science ®Google Scholar
• WangKWangYGaoLLiXLiMGuoJDexamethasone inhibits leukocyte accumulation and vascular permeability in retina of streptozotocin-induced diabetic rats via reducing vascular endothelial growth factor and intercellular adhesion molecule-1 expressionBiol Pharm Bull20083181541154618670086
   PubMed Web of Science ®Google Scholar
• GarwegJGZandiSRetinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex(R)) in its treatmentGraefes Arch Clin Exp Ophthalmol201625471257126527178087
   PubMed Web of Science ®Google Scholar
• TuuminenRLoukovaaraSIncreased intravitreal angiopoietin-2 levels in patients with retinal vein occlusionActa Ophthalmol2014922e164e16523786639
   PubMed Web of Science ®Google Scholar
• JungSHKimKASohnSWYangSJAssociation of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusionInvest Ophthalmol Vis Sci20145542290229624398091
   PubMed Web of Science ®Google Scholar
• TuuminenRLoukovaaraSHigh intravitreal TGF-beta1 and MMP-9 levels in eyes with retinal vein occlusionEye20142891095109924946846
   PubMed Web of Science ®Google Scholar
• EhlkenCGrundelBMichelsDIncreased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusionPLoS One2015105e012685925978399
   PubMed Web of Science ®Google Scholar
• SohnHJHanDHLeeDYNamDHChanges in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusionActa Ophthalmol2014923e217e22423889803
   PubMed Web of Science ®Google Scholar
• Rezar-DreindlSEibenbergerKPollreiszAEffect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusionActa Ophthalmol2017952e119e12727417275
   PubMed Web of Science ®Google Scholar
• BezatisASpitalGHohnFFunctional and anatomical results after a single intravitreal Ozurdex injection in retinal vein occlusion: a 6-month follow-up – the SOLO studyActa Ophthalmol2013915e340e34723638803
   PubMed Web of Science ®Google Scholar
• YehWSHallerJALanzettaPEffect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implantOphthalmology201211961190119822361318
   PubMed Web of Science ®Google Scholar
• MayerWJRemyMWolfAComparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edemaOphthalmologica2012228211011622739239
   PubMed Web of Science ®Google Scholar
• EterNMohrAWachtlinJDexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trialGraefes Arch Clin Exp Ophthalmol201725518927957602
   PubMed Web of Science ®Google Scholar
• ChiquetCDupuyCBronAMIntravitreal dexamethasone implant versus anti-VEGF injection for treatment-naive patients with retinal vein occlusion and macular edema: a 12-month follow-up studyGraefes Arch Clin Exp Ophthalmol2015253122095210225673251
   PubMed Web of Science ®Google Scholar
• YumusakEBuyuktortopNOrnekKEarly results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusionEur J Ophthalmol2016261545926109021
   PubMed Web of Science ®Google Scholar
• MayerWJWolfAKerntMTwelve-month experience with ozurdex for the treatment of macular edema associated with retinal vein occlusionEye201327781682223598674
   PubMed Web of Science ®Google Scholar